| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |